Study details
Enrolling now
Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
Virginia Commonwealth University
NCT IDNCT05548452ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
80
Study length
about 4.1 years
Ages
18+
Locations
2 sites in VA
About this study
Researchers are testing a treatment called Intestinal Microbiota Transplant (IMT) capsules to see if they can help with alcohol cravings and drinking. The trial will last for 1500 days, involving approximately 80 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Intestinal Microbiota Transplant (IMT) Capsules
- 2.Take Placebo Capsules
PhasePhase 1/Phase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change in health related quality of live (HRQOL), Number of serious adverse events
Body systems
Psychiatry / Mental Health, Gastroenterology